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The regulatory mechanisms governing dramatic proliferative changes during early mouse 
development are not well understood. This thesis aims to address this question using in 
vitro model systems of mouse embryogenesis. In particular, this thesis aimed to assess the 
function of the elevated, constitutive levels of cyclin dependent kinase 2 (CDK2) activity in 
embryonic stern (ES) and early primitive ectoderm-like (EPL) cells and the changes 
associated with differentiation into EPL embryoid bodies, in vitro equivalent of 
differentiation primarily to a mesodermal fate. It was determined that active CDK2 
complexes associate with an increased proportion of substrates in pluripotent ES and EPL 
cells compared to EPL embryoid bodies. In addition, this thesis assessed the presence of 
other G 1 CDK activity, determining that ES cells have high levels of constitutive CDK6 
activity, which is refractory to inhibition by p 16. Lineage specific decreases in CDK6 
activity highlighted the complexities regulating cell proliferation during differentiation. 
Due to the reported constitutive E2F target gene expression in ES cells, this thesis also 
-aimed to further analyse the regulation and activity of E2F transcription factors and pocket 
proteins in ES cells. It was demonstrated that constitutive phosphorylation of pi 07 and 
increased E2F-4 stability in ES cells contributes to increased levels of free E2F-4, that binds 
E2F target gene promoters in vivo. The importance of CDK regulation of pi 07 in ES cells 
was demonstrated by analysis of ectopic expression of phosphorylation-resistant mutant 
pi 07. The increased sensitivity of EPL cells to ectepic pI 07 highlighted differences in 
pluripotent cell populations. In addition, it was determined that differential regulation of 
pl07 during differentiation was associated with increased pi 07 binding to E2F target gene 
promoters '�d decreased E2F target gene expression. Differentiation associated changes in 
regulation and activity of cell cycle regulators demonstrated in this thesis are important for 
understanding the pre-gastrulating mouse embryo and to enable regulation of pluripotent 
cell differentiation for therapeutic use. 
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